Multimodal Interventions for Autism
(GARM-Autism Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Autism spectrum disorder (ASD) is a neurodevelopmental condition with core deficits in social communication and behavior, often accompanied by gastrointestinal (GI) and metabolic dysfunction. Emerging evidence supports the role of neuroinflammation (including autoimmune components), gut-brain axis disruption, and metabolic dysregulation in ASD pathophysiology. Multimodal interventions targeting these pathways-using autologous cSVF, cryopreserved MSCs, FMT, and dietary modulation-intent is that these multimodal interventions may offer synergistic benefits for adolescents and adults with ASD.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive multimodal interventions including autologous cSVF, cryopreserved MSCs, FMT, and ketogenic diet
Follow-up
Participants are monitored for safety and effectiveness after treatment
Open-label extension (optional)
Participants may opt into continuation of treatment long-term
What Are the Treatments Tested in This Trial?
Interventions
- Autologous cSVF + MSCs (cryo)
- FMT (Fecal Material Transplantation)
- Ketogenic RESET Diet Protocol
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
diet, bowel flora, autoimmune tracking, cSVF/MSC (cryo) multimodal approach
Find a Clinic Near You
Who Is Running the Clinical Trial?
Black Tie Medical, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.